Wanyan Ouyang

机构：Shanghai Jiao Tong University, Ruijin Hospital, Gene Therapy Laboratory, Shanghai Institute of Hematology, Shanghai Cell Therapy Research Institute · ORCID：0000-0003-2104-9439

发表论文 18 篇 · 总被引 124 次 · h-index 5

代表论文

• PD-1 downregulation enhances CAR-T cell antitumor efficiency by preserving a cell memory phenotype and reducing exhaustion (2024 · Journal for ImmunoTherapy of Cancer · 被引 56)
• Efficacy and safety of olverembatinib in adult BCR :: ABL1 ‐positive ALL with T315I mutation or relapsed/refractory disease (2024 · British Journal of Haematology · 被引 15)
• Mutations in the D1 domain of von Willebrand factor impair their propeptide-dependent multimerization, intracellular trafficking and secretion (2015 · Journal of Hematology & Oncology · 被引 14)
• Real-world advantage and challenge of post-autologous stem cell transplantation MRD negativity in high-risk patients with double-hit multiple myeloma (2024 · BMC Cancer · 被引 12)
• A novel missense mutation, p.Phe360Cys, in FIX gene results in haemophilia B in a female patient with skewed X‐inactivation (2018 · Haemophilia · 被引 6)
• The fully human anti-GPRC5D CAR T-cell therapy RD118 induces durable remissions in relapsed/refractory multiple myeloma (2025 · Blood · 被引 4)